Form 4 for KURA Kura Oncology, Inc.
Accepted 2025-09-29 00:00:00 ET · period of report 2025-09-27 · accession 0001193125-25-223662 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-09-29 | 2025-09-27 | KURA | DOYLE THOMAS JAMES | SVP, Fin, Accounting | A - Grant | $0.00 | +25.0K | 114.4K | +28% | $0 | |
| 2025-09-29 | 2025-09-29 | KURA | DOYLE THOMAS JAMES | SVP, Fin, Accounting | S - Sale | $8.94 | -4,541 | 109.8K | -4% | -$40.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-09-27 | A | A | 24,966 | $0.00 | 114,370 | D | — | — | (F1) Includes 1,211 shares acquired on May 17, 2025 pursuant to the Issuer's Employee Stock Purchase Plan. |
| 2 | Common | Common Stock | 2025-09-29 | S | D | 4,541 | $8.94 | 109,829 | D | — | — |